About Us

Tumor metabolism and tumor immunology are promising new interrelated fields for cancer drug discovery. They offer the potential for fundamentally new therapies for people with cancer and other life-threatening diseases.

Calithera’s pipeline consisting of multiple, novel compounds targets key metabolic enzymes to disrupt metabolic pathways that provide tumor and other diseased cells with nutrients they need for survival and growth, or that are important in activating the body’s own immune system to target and kill disease-causing cells.

Driven by a commitment to rigorous science and a passion for improving the lives of people impacted by cancer and other life-threatening diseases, Calithera is advancing a pipeline of first-in-clinic, oral therapeutics to meaningfully expand treatments options available to patients.